Safety Alert Or Field Safety Notices for Legendair and Supportair Portable Ventilators

According to Medicines and Healthcare products Regulatory Agency, this safety alert or field safety notices involved a device in United Kingdom that was produced by Airox.

What is this?

Field safety notices are communications sent out by medical device manufacturers or their representatives in relation to actions that they may be taking in relation to their product that is on the market. These are mainly for health workers, but also for users. They can include recalls and alerts.

Learn more about the data here
  • Type of Event
    Safety alert / Field Safety Notice
  • Event ID
  • Event Number
  • Date
  • Event Date Posted
  • Event Country
  • Event Source
  • Event Source URL
  • Notes / Alerts
    Data from the United Kingdom is current through April 2019. All of the data comes from the Medicines and Healthcare products Regulatory Agency, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and the United Kingdom.
  • Extra notes in the data
  • Reason
    Potential for the ventilator’s internal battery to fail. this can result in non-ventilation of the patient. this is due to failure of a capacitor (c53) on the printed circuit board (pcb). the ventilator will still function on external battery power and mains power. the manufacturer published a revised field safety notice (fsn) (see appendix) in july 2012 to revise the action required. the manufacturer did not receive confirmation from users that they had received and acted upon the information in the first fsn published in april 2012.
  • Action
    Locate and identify all affected ventilators. For ventilator dependent patients, contact the manufacturer for a replacement PCB and fit this as soon as possible, as per the FSN (see appendix). For non-ventilator dependent patients, contact the manufacturer for a replacement PCB (or C53 capacitor, if PCB is unavailable) which should be fitted no later than the next scheduled service, as per the FSN. In the interim, users should ensure that affected ventilators are kept on mains power, or if required for transport, that an external battery is used and a back up ventilator is available. Inform Covidien when the PCB or capacitor has been replaced for all your affected units. Be aware that the PCB or capacitor should be replaced on an annual basis as part of the revised annual preventative maintenance schedule. Ensure procedures are revised, if applicable.


  • Model / Serial
  • Product Description
    Legendair and Supportair Portable Ventilators. Specific ventilator codes (see FSN). Supplied by Airox and Covidien. These ventilators are designed primarily for use by patients at home. The affected ventilator codes are as follows: Legendair™ Single Branch 4095700 - INTL LEGENDAIR SINGLE BRANCH 4095701 - GB NO LEGENDAIR SINGLE BRANCH 4095702 - DE LEGENDAIR SINGLE BRANCH 4095705 - CA LEGENDAIR SINGLE BRANCH 4095706 - JP LEGENDAIR SINGLE BRANCH 4095709 - DK LEGENDAIR SINGLE BRANCH 4095721 - AU LEGENDAIR SINGLE BRANCH Legendair™ Double Branch 4095900 - INTL LEGENDAIR DOUBLE BRANCH 4095901 - GB NO LEGENDAIR DOUBLE BRANCH 4095902 - DE LEGENDAIR DOUBLE BRANCH 4095905 - CA LEGENDAIR DOUBLE BRANCH 4095906 - JP LEGENDAIR DOUBLE BRANCH 4095909 - DK LEGENDAIR DOUBLE BRANCH 4095921 - AU LEGENDAIR DOUBLE BRANCH Supportair™ 4096200 - INTL SUPPORTAIR 4096201 - GB SUPPORTAIR 4096202 - DE SUPPORTAIR
  • Manufacturer


  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source